Insider Trades8 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | Sell | ABUS | J. Christopher Naftzger | General Counsel and CCO | 11,333 | $3.28 | $1.0B | -4.59% | +49.00% | $37.2K | -11.61% | 10b5-1 | Buy Now |
| Feb 4, 2025 | Sell | ABUS | Karen Sims | Chief Medical Officer | 19,348 | $3.28 | $1.0B | -4.59% | +49.00% | $63.5K | -15.41% | 10b5-1 | Buy Now |
| Feb 4, 2025 | Sell | ABUS | David C Hastings | Chief Financial Officer | 22,183 | $3.28 | $1.0B | -4.59% | +49.00% | $72.8K | -12.19% | 10b5-1 | Buy Now |
| Feb 4, 2025 | Sell | ABUS | Michael J. Mcelhaugh | Interim President & CEO | 23,790 | $3.28 | $1.0B | -4.59% | +49.00% | $78.1K | -1.58% | 10b5-1 | Buy Now |
| Feb 2, 2024 | Sell | ABUS | Karen Sims | Chief Medical Officer | 4,358 | $2.31 | $1.0B | -4.59% | +49.00% | $10.1K | -0.82% | 10b5-1 | Buy Now |
| Feb 2, 2024 | Sell | ABUS | David C Hastings | Chief Financial Officer | 9,593 | $2.31 | $1.0B | -4.59% | +49.00% | $22.2K | -1.50% | 10b5-1 | Buy Now |
| Feb 2, 2024 | Sell | ABUS | Michael J. Sofia | Chief Scientific Officer | 9,982 | $2.31 | $1.0B | -4.59% | +49.00% | $23.1K | -0.52% | 10b5-1 | Buy Now |
| Feb 2, 2024 | Sell | ABUS | Michael J. Mcelhaugh | Interim President & CEO | 10,164 | $2.31 | $1.0B | -4.59% | +49.00% | $23.5K | -0.51% | 10b5-1 | Buy Now |